Some studies have raised questions about a possible relationship between vasectomy (an operation to cut or tie off the two tubes that carry sperm out of the testicles) and the risk of developing cancer, particularly prostate and testicular cancer. Such a relationship, if proven, would be of importance because about 1 in 6 men over age 35 in the United States has had a vasectomy.
Prostate cancer is the most common cancer in American men and the second leading cause of cancer death in American men, after lung cancer. In March 1993, the National Institute of Child Health and Human Development (NICHD) convened a conference, cosponsored by the National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases, to clarify the available evidence on the relationship between vasectomy and prostate cancer. Scientists reviewed and carefully weighed all of the data available at that time, including results from published and unpublished studies.
They determined that the results of research on the association between vasectomy and prostate cancer were not consistent. In addition, the scientists could not find any convincing biological explanation for a link between vasectomy and an increased risk of prostate cancer. Based on these findings, the expert panel concluded that even if having a vasectomy can increase a man's risk of developing prostate cancer, the increase in risk is relatively small.
In 1997, the NCI convened the prostate cancer Progress Review Group (PRG), a committee that included members from the scientific, medical, industrial, and advocacy communities. This group was charged with developing a national plan to outline scientific efforts involving prostate cancer research. The PRG's final report, published in August 1998, concluded that the evidence supporting a role for vasectomy in the development of prostate cancer is weak.
Researchers continue to investigate the possible relationship between vasectomy and prostate cancer. The majority of studies conducted thus far have upheld the conclusions made at the 1993 NICHD conference. Although a few studies have reported a link between vasectomy and prostate cancer, it is possible that other factors, including chance, may be responsible for the association suggested in these studies.
Testicular cancer is much less common than prostate cancer, accounting for approximately 1 percent of all cancers in American men. This type of cancer is most often found in men ages 15 to 35. A few studies have suggested a link between vasectomy and an increased risk of testicular cancer, but the evidence is inconsistent and the association in some studies may be due to factors other than vasectomy. It is also possible that the vasectomy procedure increases the rate at which an existing, but undetected, testicular cancer will progress. At this time, it is believed that there is either no association or a weak association between vasectomy and testicular cancer, although more research is needed before definitive conclusions can be reached.
Men concerned about prostate cancer or testicular cancer should talk to their doctor about the symptoms to watch for and an appropriate schedule for checkups.
Brawley OW, Knopf K, Thompson I. The epidemiology of prostate cancer part II: The risk factors. Seminars in Urologic Oncology 1998; 16(4):193-201.
Cox B, Sneyd MJ, Paul C, Delahunt B, Skegg DC. Vasectomy and risk of prostate cancer. Journal of the American Medical Association 2002; 287(23):3110-3115.
Dennis LK, Dawson DV, Resnick MI. Vasectomy and the risk of prostate cancer: A meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer and Prostatic Diseases 2002; 5(3):193-203.
Lesko SM, Louik C, Vezina R, Rosenberg L, Shapiro S. Vasectomy and prostate cancer. Journal of Urology 1999; 161(6):1848-1852.
Lightfoot N, Kreigr N, Sass-Kortsak A, Purdham J, Buchan G. Prostate cancer risk. Medical history, sexual, and hormonal factors. Annals of Epidemiology 2000; 10(7):470.
Lynge E. Prostate cancer is not increased in men with vasectomy in Denmark. Journal of Urology 2002; 168(2):488-490.
National Cancer Institute. Defeating Prostate Cancer: Crucial Directions for Research: Report of the Prostate Cancer Progress Review Group. August 1998.
Schwingl PJ, Guess HA. Safety and effectiveness of vasectomy. Fertility and Sterility 2000; 73(5):923-936.
Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK. Vasectomy and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention 1999; 8(10):881-886.
Source: U.S. National Institutes of Health, National Cancer Institute, http://www.cancer.gov